- Home
- Publications
- Publication Search
- Publication Details
Title
Could live attenuated vaccines better control COVID-19?
Authors
Keywords
COVID-19, SARS-CoV-2, Live attenuated vaccine, Vaccine
Journal
VACCINE
Volume 39, Issue 39, Pages 5719-5726
Publisher
Elsevier BV
Online
2021-08-11
DOI
10.1016/j.vaccine.2021.08.018
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adaptive immunity to SARS-CoV-2 and COVID-19
- (2021) Alessandro Sette et al. CELL
- Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis
- (2021) Bryan A. Johnson et al. NATURE
- Emergence of SARS-CoV-2 B.1.1.7 Lineage — United States, December 29, 2020–January 12, 2021
- (2021) Summer E. Galloway et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- In adults, the Oxford/AstraZeneca vaccine had 70% efficacy against COVID-19 >14 d after the 2nd dose
- (2021) Zain Chagla ANNALS OF INTERNAL MEDICINE
- In high-risk adults, the Moderna vaccine had 94% efficacy against COVID-19 ≥14 d after the 2nd dose
- (2021) Zain Chagla ANNALS OF INTERNAL MEDICINE
- The BNT162b2 (BioNTech/Pfizer) vaccine had 95% efficacy against COVID-19 ≥7 days after the 2nd dose
- (2021) Zain Chagla ANNALS OF INTERNAL MEDICINE
- Robust SARS-CoV-2 infection in nasal turbinates after treatment with systemic neutralizing antibodies
- (2021) Dongyan Zhou et al. Cell Host & Microbe
- SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma
- (2021) Constantinos Kurt Wibmer et al. NATURE MEDICINE
- S-Trimer, a COVID-19 subunit vaccine candidate, induces protective immunity in nonhuman primates
- (2021) Joshua G. Liang et al. Nature Communications
- The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Janssen COVID-19 Vaccine — United States, February 2021
- (2021) Sara E. Oliver et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Sequelae in Adults at 6 Months After COVID-19 Infection
- (2021) Jennifer K. Logue et al. JAMA Network Open
- Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant
- (2021) Xianding Deng et al. CELL
- Side effects of BNT162b2 mRNA COVID-19 vaccine: A randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers
- (2021) Renuka A.K. Kadali et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia
- (2021) Douglas B. Cines et al. NEW ENGLAND JOURNAL OF MEDICINE
- Establishment of a reverse genetics system for SARS-CoV-2 using circular polymerase extension reaction
- (2021) Shiho Torii et al. Cell Reports
- Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy
- (2021) Ying Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- A codon-pair deoptimized live-attenuated vaccine against respiratory syncytial virus is immunogenic and efficacious in non-human primates
- (2020) Steffen Mueller et al. VACCINE
- Increasing the Safety Profile of the Master Donor Live Attenuated Influenza Vaccine
- (2020) Thomas A. Hilimire et al. Pathogens
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Engineering the Live-Attenuated Polio Vaccine to Prevent Reversion to Virulence
- (2020) Ming Te Yeh et al. Cell Host & Microbe
- Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
- (2020) Jun Lan et al. NATURE
- Cell entry mechanisms of SARS-CoV-2
- (2020) Jian Shang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Development of an inactivated vaccine candidate for SARS-CoV-2
- (2020) Qiang Gao et al. SCIENCE
- Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
- (2020) Xiuyuan Ou et al. Nature Communications
- Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding
- (2020) Tyler N. Starr et al. CELL
- Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques
- (2020) Noe B. Mercado et al. NATURE
- ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
- (2020) Neeltje van Doremalen et al. NATURE
- Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies
- (2020) Alina Baum et al. SCIENCE
- Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody
- (2020) Zhe Lv et al. SCIENCE
- Cytokine storm induced by SARS-CoV-2
- (2020) Peipei Song et al. CLINICA CHIMICA ACTA
- Recombinant human p53 adenovirus injection (rAd-p53) combined with chemotherapy for 4 cases of high-grade serous ovarian cancer
- (2020) Hui Qu et al. CURRENT GENE THERAPY
- Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome
- (2020) Chengjin Ye et al. mBio
- An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques
- (2020) Liqiang Feng et al. Nature Communications
- T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
- (2020) Katie J. Ewer et al. NATURE MEDICINE
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enhanced SARS-CoV-2 neutralization by dimeric IgA
- (2020) Zijun Wang et al. Science Translational Medicine
- Early transmission of SARS-CoV-2 in South Africa: An epidemiological and phylogenetic report
- (2020) Jennifer Giandhari et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Analysis of coronavirus temperature-sensitive mutants reveals an interplay between the macrodomain and papain-like protease impacting replication and pathogenesis
- (2019) Xufang Deng et al. JOURNAL OF VIROLOGY
- Design, Assembly, Production, and Transfection of Synthetic Modified mRNA
- (2018) Sanders Oh et al. METHODS
- A Single Mutation at PB1 Residue 319 Dramatically Increases the Safety of PR8 Live Attenuated Influenza Vaccine in a Murine Model without Compromising Vaccine Efficacy
- (2015) Andrew Cox et al. JOURNAL OF VIROLOGY
- The most ambitious vaccine introduction in history
- (2014) Elizabeth Miller VACCINE
- Pre-existing immunity against Ad vectors
- (2014) Hugues Fausther-Bovendo et al. Human Vaccines & Immunotherapeutics
- Cell-mediated immune responses to a varicella-zoster virus glycoprotein E vaccine using both a TLR agonist and QS21 in mice
- (2012) Najoua Dendouga et al. VACCINE
- Annual Vaccination against Influenza Virus Hampers Development of Virus-Specific CD8+ T Cell Immunity in Children
- (2011) R. Bodewes et al. JOURNAL OF VIROLOGY
- Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons
- (2010) Lisa A Jackson et al. BMC INFECTIOUS DISEASES
- Coronaviruses post-SARS: update on replication and pathogenesis
- (2009) Stanley Perlman et al. NATURE REVIEWS MICROBIOLOGY
- Virus Attenuation by Genome-Scale Changes in Codon Pair Bias
- (2008) J. R. Coleman et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More